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Lumazine synthase from Brucella spp. (BLS) is a highly immunogenic decameric protein
which can accommodate foreign polypeptides or protein domains fused to its N-termini,
markedly increasing their immunogenicity. The inner core domain (VP8d) of VP8 spike
protein from bovine rotavirus is responsible for viral adhesion to sialic acid residues
and infection. It also displays neutralizing epitopes, making it a good candidate for
vaccination. In this work, the BLS scaffold was assessed for the first time in plants for
recombinant vaccine development by N-terminally fusing BLS to VP8d and expressing
the resulting fusion (BLSVP8d) in tobacco chloroplasts. Transplastomic plants were
obtained and characterized by Southern, northern and western blot. BLSVP8d was
highly expressed, representing 40% of total soluble protein (4.85 mg/g fresh tissue).
BLSVP8d remained soluble and stable during all stages of plant development and
even in lyophilized leaves stored at room temperature. Soluble protein extracts from
fresh and lyophilized leaves were able to induce specific neutralizing IgY antibodies
in a laying hen model. This work presents BLS as an interesting platform for highly
immunogenic injectable, or even oral, subunit vaccines. Lyophilization of transplastomic
leaves expressing stable antigenic fusions to BLS would further reduce costs and
simplify downstream processing, purification and storage, allowing for more practical
vaccines.
Keywords: bovine rotavirus, transplastomic plants, tobacco, BLS, VP8, vaccine, lyophilized, IgY
INTRODUCTION
Rotavirus is the main cause of severe gastroenteritis in newborn mammals and constitutes severe
economic losses across the world (Saif and Fernandez, 1996). According to a ten year study
spanning from 1994 to 2003, group A bovine rotavirus (BRV) is the main cause of neonatal
diarrhea in calves in Argentina, being responsible for substantial economic constraints concerning
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beef and dairy herd (Garaicoechea et al., 2006). Calves are
particularly susceptible to rotavirus infection during the ﬁrst
weeks of life and for that reason it becomes essential to count
with an eﬀective system of passive immunization comprising
transmission of colostrum and milk antibodies originated from
active vaccination of the mothers (Fernandez et al., 1998).
Bovine rotavirus is composed of 11 segments of double-
stranded RNA enclosed in an inner core, surrounded by
two protein layers that constitute the viral capsid. The outer
layer is in turn formed by two diﬀerent proteins, VP7 and
VP4 (Estes et al., 2001). The latter possess hemagglutinating
activity and participates in viral adsorption (Kalica et al.,
1983; Crawford et al., 1994). VP4 is further cleaved into VP8
and VP5 by proteolytic enzymes in the gastrointestinal tract,
being the non-glycosylated VP8 domain the one responsible
for viral adhesion to sialic acid residues on the host cells.
VP8 also displays neutralizing epitopes which makes it a good
candidate for recombinant vaccines (Ruggeri and Greenberg,
1991).
Plant molecular farming oﬀers a low-cost and easy to scale-up
alternative for production of recombinant proteins. Plastid
genome transformation oﬀers interesting advantages over
nuclear transformation for the development of commercial
vaccines. Most importantly, the resulting transplastomic plants
often present expression levels which are considerably higher
than those typically obtained from nuclear transgenic plants.
This is a consequence of the polyploidy of the chloroplast
genome and the lack of silencing or position eﬀects since the
integration events proceed by homologous recombination
(Bock, 2007). Furthermore, since chloroplast are maternally
inherited in most crops, transplastomic plants imply a
lower risk of horizontal gene transfer (Ruf et al., 2007).
Particularly, plastid transformation has been extensively
involved in the production of antigens, a large number of
them are of interest for veterinary medicine (Ruiz et al.,
2015).
Lyophilization of transplastomic leaves provides additional
beneﬁts which further reduce costs and simplify processing,
puriﬁcation, storage and immunization. It can further
concentrate the recombinant products, which can be stable
(preserving proper folding and disulﬁde bond formation) even
after prolonged storage at room temperature, thus eliminating
the need for cold chain and facilitating transportation (Su et al.,
2015). Furthermore, lyophilization also removes microbial
contamination from fresh leaves, making oral delivery with
powdered lyophilized material in capsules safer (Kwon et al.,
2013a).
The C486 BRV VP8∗ protein was previously expressed in
tobacco chloroplasts, mostly as insoluble aggregates, and it has
already been demonstrated that it conferred a strong immune
response in female mice. Moreover, suckling mice born to
immunized dams were protected against oral challenge with
virulent rotavirus (Lentz et al., 2011).
The enzyme lumazine synthase from Brucella spp. (BLS) has
been described as a novel protein carrier for antigen delivery
based on its remarkable physicochemical and immunogenic
properties. BLS folds as a highly stable dimer of pentamers,
each subunit exposing a N-terminus which can accommodate
foreign polypeptides or protein domains without aﬀecting the
folding and stability of the decamer as a whole (Zylberman
et al., 2004). This characteristic was conﬁrmed by structural
analyses of the resulting chimeras. BLS overall structure
and characteristics resemble those of the highly stable and
immunogenic B subunit of the cholera toxin (CTB) and the
Escherichia coli heat-labile enterotoxin subunit B (LTB), both
of which have been broadly used as potent adjuvants to boost
immunogenic response when coupled with foreign antigens.
In fact, both adjuvants were already successfully expressed
as antigenic fusions in transplastomic plants (Waheed et al.,
2011; Lakshmi et al., 2013). BLS also behaves as a potent
immunomodulator (Velikovsky et al., 2002; Berguer et al.,
2006). It is capable of inducing both humoral and cell-
mediated responses (Velikovsky et al., 2003). It should be
noted that BLS immunogenic properties only become evident
when it is expressed as a fusion and not when it is co-
expressed along with the antigen (Craig et al., 2005). Owing
to its multivalence and immunogenic properties, BLS was
successfully proven as an eﬃcient carrier and adjuvant both
for systemic and oral immunization (Rosas et al., 2006). More
speciﬁcally, the N-terminal end of BLS was fused to the
inner domain of the VP8 protein (VP8d) and expressed in
E. coli. The resulting fusion (BLSVP8d) folded and assembled
properly and elicited higher antibody titers than VP8d alone
or a mixture of VP8d and BLS, both in female mice
and in laying hen models. In the ﬁrst case, suckling mice
born to immunized dams were also protected against oral
challenge with virulent rotavirus (Bellido et al., 2009), while
immunoglobulin Y (IgY) antibodies against BLSVP8d produced
in hens were able to fully protect mice against oral challenge
with virulent BRV in a dose-dependent-manner (Bellido et al.,
2012).
In this work, and for the ﬁrst time, the BLS scaﬀold
was assessed in a recombinant plant system. We expressed
the BLSVP8d fusion in tobacco (Nicotiana tabacum L. cv.
Petit Havana) chloroplasts to evaluate the possible use of
this antigen for vaccine development. Its immunogenicity was
assessed in a laying hen model. Our results demonstrate
that BLSVP8d fusion readily accumulated, was highly stable
without signiﬁcant proteolytic degradation and was expressed
in soluble form at very high levels in transplastomic leaves.
Moreover, the fusion protein remained stable and could be
detected in its soluble form in high levels in lyophilized
leaves, even after one month storage at room temperature.
Unpuriﬁed fresh and lyophilized leaf soluble protein extracts
were able to induce speciﬁc neutralizing IgY antibodies in
egg yolk. This work presents an interesting platform for a
highly immunogenic injectable, or even oral, VP8∗ subunit
vaccine. Our results also provide the basis for expression of
other subset of antigens in transplastomic plants making use
of the highly immunogenic BLS antigen scaﬀold. Furthermore,
lyophilization of transplastomic leaves expressing stable antigenic
fusions to BLS would facilitate the processing, puriﬁcation
and storage, reducing costs and allowing for more practical
vaccines.
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MATERIALS AND METHODS
Chloroplast Transformation Vector
Construction
The DNA fragment coding for BLSVP8d, in which VP8d
is fused to the N-termini of BLS, was obtained from
pET-BLS-VP8d (Bellido et al., 2009) by PCR with Pfu
DNA polymerase (Invitrogen, Carlsbad, USA) using primers
BLSVP8dNdeI (5′ CCCATATGCATGAACCAGTGCTTG 3′)
and BLSVP8dXbaI (5′ CCTCTAGATCAGACAAGCGCGATGC
3′). Primers included NdeI and XbaI restriction sites to allow
further cloning. The ampliﬁcation product was subcloned into
pZErO-2 (Invitrogen Life Technologies, Carlsbad, SD, USA)
and sequenced. BLSVP8d was released by enzymatic digestion
with NdeI and XbaI, gel puriﬁed and cloned into chloroplast
transformation vector pBSW-utr/hEGF (Wirth et al., 2006),
which was previously digested with NdeI and XbaI to excise
the hEGF sequence. The resulting construction was named
pBSW-utr/BLSVP8d and carries the BLSVP8d sequence under
the control of the promoter and 5′-untranslated region of the
tobacco psbA gene (5′psbA) and downstream the aadA sequence
that confers spectinomycin resistance, under the transcriptional
control of the rrn promoter (Prrn). Flanking regions were
included to allow homologous recombination with N. tabacum
plastome (GenBank accession number NC 001879). The left
ﬂanking region (LFR) included the 3′ region of rrn16, and the
right ﬂanking region (RFR) contained the full trnI and the
5′region of trnA, all from N. tabacum.
Chloroplast Transformation and
Molecular Characterization of
Transplastomic Plants
Chloroplast transformation was carried out as previously
described (Svab et al., 1990), using a PDS 1000/He biolistic
device (Bio-Rad, USA). Fully expanded leaves of in vitro cultured
N. tabacum cv. Petit Havana plants were bombarded with 50 mg
of 0.6 μm gold particles (Bio-Rad) coated with 2 μg of plasmid
DNA, using 1,100 psi rupture disks (Bio-Rad). Transformed
shoots were regenerated in selective RMOP regeneration medium
containing 500 mg/l spectinomycin dihydro-chloride. To obtain
homoplastic plants, leaves from PCR-positive shoots were cut
into pieces and taken through two additional regeneration cycles
in selective medium. After rooting, plants were transferred to
soil and grown under greenhouse conditions. In the greenhouse,
natural light was supplemented 16 h/day by sodium lamps
providing 100–300 μmol s−1 m−2, temperature was set at 26◦C
during day and 19◦C in the night.
PCR Analysis to Confirm Transplastomic
State
DNA obtained from leaf material of spectinomycin resistant and
wild-type (wt) plants was used as template for ampliﬁcation
with primers Cl Fw (5′-GTATCTGGGGAATAAGCATCGG-3′)
and Cl Rev (5′- CGATGACGCCAACTACCTCTG-3′). Cl Fw
hybridizes upstream of the LFR to 16S wt gene and Cl Rev
hybridizes to the aadA sequence. Therefore, a 1450 bp fragment
was only ampliﬁed from transplastomic plants.
The PCR reaction was conducted in a total volume of 50 μl,
containing 10 ng of leaf total DNA, 10X PCR buﬀer, 400 μM
dNTP mix, 150 ng of each primer, and 1 U Taq polymerase
(Invitrogen Corp., Carlsbad, SD, USA). The reaction conditions
were as follows: initial denaturalization (95◦C, 5 min) was
followed by 30 ampliﬁcation cycles (denaturing, 95◦C, 30 s;
annealing, 55◦C, 60 s, and extension 72◦C, 90 s) and a 10 min
ﬁnal extension step at 72◦C.
Southern Blot
Total DNA was extracted from leaves as described by Dellaporta
et al. (1984). The DNA (2.5 μg) was digested overnight with
NcoI enzyme (New England Biolabs, USA), electrophoresed
in 0.8% agarose gels and blotted onto Hybond-N+ Nylon
membranes (Amersham Biosciences, USA). Speciﬁc DNA
sequences were detected by hybridization with α-32P-labeled
trnI/A DNA probe. The probe was generated by random
priming with a Prime-a-Gene kit (Promega, USA). Pre-
hybridization and hybridization were carried out at 65◦C in
Church’s hybridization solution (Church and Gilbert, 1984)
for 2 and 16 h, respectively. Membranes were washed twice
with gentle shaking for 30 min in 0.2X SSC, 0.1% SDS at
65◦C. The blot was exposed to a storage phosphor screen,
which was analyzed in a Storm 840 PhosphorImager system
(Amersham).
Northern Blot
Total RNA was extracted from fully expanded young leaves
using TRiZOL Reagent (Invitrogen Corp., Carlsbad, SD, USA).
An aliquot of 5 μg of formaldehyde-denatured RNA was
electrophoresed in a 1.5% agarose/formaldehyde gel and blotted
onto Hybond-N+ Nylon membranes (Amersham Biosciences).
Speciﬁc mRNA sequences were detected by hybridization with
α-32P-labeled bls DNA probe generated by random priming
with a Prime-a-Gene kit (Promega). The blot was pre-
hybridized, hybridized and washed as described for Southern
blot.
Total Protein Analysis
Total protein content from transformed and non-transformed
plants was extracted by grinding 25 mg of fresh leaf material
in 125 μl of Laemmli buﬀer. Diﬀerent quantities of samples
were electrophoresed in 12.5% SDS-PAGE gels for either
Coomassie blue staining or western blotting. For western blot,
proteins were transferred onto a nitrocellulose membrane.
The membrane was probed with mouse antiserum against
VP8 or BLS, followed by three washes with 50 mM Tris-
HCl, pH 8, 150 mM NaCl, 0.05% Tween 20, and a second
incubation step with an alkaline phosphatase-linked goat anti-
mouse IgG antibody diluted to 1:2000. Finally, phosphatase
activity was determined by a chromogenic reaction by
addition of NBT/BCIP (Nitro blue tetrazolium/5-Bromo-4-
chloro-3-indolyl phosphate; Sigma Chemical Co., USA) as
substrates.
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BLSVP8d Solubility Analysis and
Quantification
Total protein from 200 mg of fully expanded leaves from
transformed and non-transformed plants was extracted in
1 ml of protein extraction buﬀer (50 mM Tris–HCl, pH
8, 30 mM NaCl). For lyophilized leaves, approximately 1/10
of leaf was added per ml of extraction buﬀer. Brieﬂy, leaf
material was ground in liquid nitrogen, mixed with extraction
buﬀer and sonicated three times for 15 s with a microtip
(Heat System Ultrasonic, Farmingdale, NY, USA) set at level
50%, and then centrifuged for 15 min at 10,000 × g, 4◦C.
The supernatant and pellet fractions contained soluble and
insoluble proteins, respectively. The pellet was washed three
times with 1 ml water at 0◦C. Samples from each fraction
(total, soluble, insoluble) were mixed with Laemmli buﬀer and
were electrophoresed in 12.5% SDS-PAGE for either Coomassie
blue staining or western blotting. Total soluble protein (TSP)
content from supernatant fractions was quantiﬁed by Bradford
assay using bovine serum albumin (BSA; Sigma Aldrich)
as standard. For recombinant protein level quantiﬁcation,
gels were scanned and protein bands were quantiﬁed using
Image J software (NIH, http://rsbweb.nih.gov/ij). For western
blot, proteins were transferred onto nitrocellulose membrane.
Membranes were treated as described before for total protein
analysis.
Lyophilization
Fully expanded leaves from transformed and non-transformed
plants were cut into small fragments measuring roughly 1 cm2.
Fragments were frozen at −80◦C and then lyophilized in a
Freezone Lyph-Lock 6 Freeze Dry System (Labconco) in vacuum
(0.13 mBar) for at least 1 day at−40◦C. Lyophilized samples were
stored at −80◦C or at room temperature.
Animal Immunization
Soluble quantiﬁed extracts from either fresh or lyophilized
leaves from transformed and non-transformed plants were
used for immunization of groups of light brown laying hens
(n = 2) seronegatives for BRV. Groups were inoculated with
3.83 μg of BLSVP8d of which 2 μg corresponded to VP8d.
Recombinant fresh and lyophilized extracts were normalized with
the corresponding non-transformed extracts. Hens received three
intramuscular doses of 0.5 ml, on days 0, 30, and 75, consisting of
Freund’s incomplete adjuvant:antigen in a proportion of 50:50.
Laying capacity and the sites of injection were checked for side
eﬀects. Eggs were collected on day 0 and then weekly, 15 days
after the third immunization, on days 87, 94, and 103 (DPI).
Hens were obtained from the biotery of the CICVyA, INTA.
Animal immunization, management and sample collection were
conducted by trained personnel under the supervision of a
veterinarian, in accordance with protocols approved by INTA’s
ethical committee of animal welfare.
Antibody Measurements by ELISA
The egg yolk puriﬁcation protocol was adapted from Akita
and Nakai (1993). Egg yolks were diluted with ﬁve volumes of
distilled water, frozen at −80◦C, thawed on ice and centrifuged
at 4◦C for 10 min at 8,000 × g. The supernatant was stored at
4◦C and used for IgY analysis. Titers of IgY against BLSVP8d
were determined according to Bellido et al. (2012). Brieﬂy,
1 μg of puriﬁed VP8d was directly adsorbed onto each well
overnight in carbonate-bicarbonate buﬀer pH 9.6 and blocked
with PBS-T, 5% normal horse serum for 1 h at 37◦C. Blocking
buﬀer was discarded and fourfold dilutions, starting at a 1/20
dilution, of all IgY samples in blocking buﬀer were incubated
for 1 h at 37◦C. Wells were then washed with PBS-T and
incubated with horseradish peroxidase-labeled goat anti-chicken
IgY (Sigma Chemical Co., USA). After thorough washing, the
reaction was developed with ABTS/H2O2 system and stopped
by addition of 5% SDS. Absorbance was measured at 405 nm
(A405) in a Multiskan Ex, Labsystems Inc. The cut-oﬀ value of
the assay was calculated as the mean speciﬁc optical density (OD)
plus 3 standard deviations from IgY puriﬁed samples obtained
from hens immunized with soluble wild-type plant extracts.
A previously puriﬁed IgY against BLSVP8d expressed in E. coli
was used as a positive control.
Titers were expressed as the reciprocal of the highest IgY
dilution which presented an OD value above the cut-oﬀ value.
Viral Neutralization Assay
Virus-neutralizing titers were determined by a ﬂuorescent
focus reduction test as previously described (To et al., 1998).
Brieﬂy, serial diluted samples of IgY antibody fractions
were mixed with an equal volume of C486 strain BRV in
order to have 100 ﬂuorescent focus-forming (FFU)/100 μL
of mixture that was incubated for 1 h at 37◦C. Then they
were inoculated onto MA-104 monolayers (four replicates)
and were further incubated for 48 h at 37◦C. Plates were
then ﬁxed with 70% acetone and were developed using
a ﬂuorescein isothiocyanate-labeled anti-BRV polyclonal
antibody derived from the hyperimmunization of a colostrum-
deprived calf. Samples that generated >80% reduction of
the infection rate were considered protective. The viral
neutralization titer was calculated by the Reed and Muench
(1938) method considering the highest sample dilution that
resulted positive.
RESULTS
Production of Transplastomic
N. tabacum Expressing BLSVP8d
Expression from chloroplast transformation vector pBSW-
utr/BLSVP8d (Figures 1A,B) was ﬁrst assessed in Escherichia
coli extracts since the prokaryotic protein synthesis machinery
can recognize plastid transcriptional and translational elements.
E. coli does not necessarily reﬂect the environment of the
chloroplast stroma, nevertheless it provides a fast method for
testing the ﬁnal genetic construction. The recombinant protein
accumulated to high levels in bacteria, being detectable both by
SDS-PAGE followed by Coomassie blue staining and western blot
(data not shown).
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FIGURE 1 | Chloroplast transformation vector and analysis of transgene integration. (A) Chloroplast genome (WT cpDNA) physical map at the insertion site
(dotted lines) showing the left and right flanking recombinogenic regions (LFR and RFR). (B) Vector pBSW-utr/BLSVP8d contains VP8d from BRV strain C486
sequence fused to Brucella spp. lumazine synthase (BLS) under the 5′ untranslated sequence and the promoter of the psbA gene (5′psbA). The LFR includes the 3′
region of rrn16, and the RFR contains the full trnI and the 5′region of trnA. The aadA sequence is under the control of the Prrn promoter. rrn23: sequence coding the
23S rRNA (Wirth et al., 2006). trnI/A: probe used in Southern blot assays. Arrows indicate the location of the forward (Cl Fw) and reverse (Cl Rev) primers used for
the PCR analysis. (C) PCR analysis to confirm integration of the recombinant vector into the wild-type plastome. WT: wild-type tobacco plant. The plasmid used for
plant transformation was included as a positive control (+). The position of Lambda BstEII marker is indicated on the left. (D) Southern blot using trnI/A probe to
confirm integration and homoplasmy (wild-type plastome: 6.4 kbp, transformed plastome: 8.8 kbp). The position of 1-kb DNA marker is indicated on the left. (A−C)
independent BLSVP8d transplastomic lines.
Chloroplasts from in vitro tobacco plants (N. tabacum L. cv.
Petite Havana) were then transformed by particle bombardment
using vector pBSW-utr/BLSVP8d. Several regenerating shoots
were obtained and three of them representing independent
plastid-transformed (transplastomic) lines were further
conﬁrmed by PCR (Figure 1C). These lines were subjected
to two additional rounds of regeneration on spectinomycin
supplemented media to achieve homoplasmy. Rooted plants
were transferred to soil and further grown under greenhouse
conditions. Surface sterilized seeds from these plants were
germinated in spectinomycin containing media to conﬁrm
maternal inheritance of the transgenes and the absence of
wild-type plastomes. Germinated plants were transferred to
greenhouse for further analysis. Phenotypic comparison to
wild-type plants revealed that they are indistinguishable from
their non-transformed counterparts (Supplementary Figure S1).
Analysis of Transgene Integration and
Homoplastic State
Southern blot was performed in order to evaluate stable
integration into the plastome and homoplasmy of spectinomycin
resistant lines germinated from seeds. For this purpose total leaf
DNA was digested with NcoI, whose recognition sequence is
absent in the integrated cassette of transplastomic plants and
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FIGURE 2 | Characterization of transcripts and BLSVP8d expression. (A) Physical map showing expected transcripts generation from the integrated cassette.
(I) polycistronic read-through transcript (3.8 kb) (II) biscistronic transcript (2.2 kb). (III) monocistronic transcript (1.2 kb). (B) Northern blot using bls probe showing
transcript generation. Transcripts are shown relative to 25S and 16S ribosomal RNA (3.7 and 1.5 kb, respectively). The 25S rRNA is shown as total RNA lane load
control. (C) 12.5% SDS-PAGE gel stained with Coomassie brilliant blue and (D) western blot using an antiserum against VP8∗. Total protein from 3 mg of
transplastomic WT, BLSVP8d, and VP8∗ leaves was extracted in Laemmli buffer. Transplastomic VP8∗ extract was included as a positive control. The position of
molecular weight marker (Novex Sharp Pre-Stained Protein Standard) is shown on the right. BLSVP8d (35,5 KDa), VP8∗ (31 KDa), and RuBisCo large subunit (RbcL)
positions are shown on the left. (A−C) independent BLSVP8d transplastomic lines.
which cuts both upstream and downstream of the integration
site in the plastome. Therefore, bands of approximately 6.4 and
8.8 kbp are expected for wild-type and transplastomic plastomes,
respectively, when using a 32P-labeled probe comprising a
fragment from trnI/trnA. Southern blot analysis conﬁrmed the
integration for all the evaluated lines (Figure 1D).
Analysis of Transcripts
Northern blot was performed to evaluate the presence of
transcripts containing the BLSVP8d sequence. Total leaf RNA
was probed with a sequence homologous to bls and as a result
three major transcripts could be detected in all transplastomic
lines. The strong promoter psbA accounted for the smallest
and most abundant monocistronic transcript, the rrn promoter
included in the cassette controlling aadA and BLSVP8d
expressionwas responsible for a bicistronic transcript and a larger
transcript aroused from read-through transcription from an
endogenous rrn promoter (Figures 2A,B). Expected transcripts
were approximately 1.2 kb for the monocistron, 2.2 kb for the
bicistron and 3.8 kbp for the larger one. This interpretation is
supported by comparing the electrophoretic mobility of these
three transcripts relative to the one of rRNA 25S and 16S (3.7 and
1.5 kb, respectively).
BLSVP8d Expression and Stability in
Fresh Leaves
Expression of BLSVP8d was assessed in total protein extracts
of all transplastomic lines. An intense diﬀerential band of
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FIGURE 3 | BLSVP8d accumulation along development and quantification of soluble BLSVP8d in fresh leaf. (A) 12.5% SDS-PAGE gel stained with
Coomassie brilliant blue. Total protein was extracted in Laemmli buffer from 2 mg of different leaves along a BLSVP8d plant. Positions of molecular weight marker
(Broad Range Protein Molecular Weight Markers), BLSVP8d and RbcL are indicated on the margins. (B) Transplastomic BLSVP8d plant used in the stability assay.
Leaves were numbered from the first expanded leaf from the top to the bottom. (C) 12.5% SDS-PAGE gel stained with Coomassie brilliant blue showing different
quantities of total soluble protein from an intermediate transplastomic BLSVP8d leaf (leaf 7). BLSVP8d was quantified against a calibration curve of Bovine Serum
Albumin (BSA). A total wild-type extract was used as control. Protein extract quantities, RbcL, BLSVP8d, and molecular weight marker (Broad Range Protein
Molecular Weight Markers) positions are indicated on the margins.
approximately 35 kDa and compatible with BLSVP8d expected
molecular weight was evident for the three independent lines
and absent in the wild-type control after Coomassie blue staining
of a SDS-PAGE. Its identity was further conﬁrmed by western
blot using an antiserum raised against a larger version of
VP8d produced in E. coli (VP8∗) (Bellido et al., 2009). A total
extract from a transplastomic plant expressing VP8∗ which was
previously generated at our lab was included as a positive control
(Lentz et al., 2011). Remarkably, the band corresponding to
BLSVP8d was even more intense than that of Rubisco large
subunit (RuBisCo; Figures 2C,D).
Age-related leaf protein content decline can be exploited
to evaluate recombinant protein stability (Birch-Machin et al.,
2004; Zhou et al., 2008). In order to evaluate BLSVP8d stability,
total protein extracts from leaves along a transplastomic line
were examined by Coomassie blue staining (Figures 3A,B).
BLSVP8d fusion readily accumulated in younger leaves and
it remained highly stable in mature and even in senescent
leaves, without showing any important signs of proteolysis.
The highest expression levels were observed in old leaves.
In contrast, RuBisCo large subunit and the majority of
other proteins were gradually degraded due to senescence
mechanisms. BLSVP8d levels were similar to, or greater
than, those of RuBisCo depending on the leaf selected
(Figures 3A,B).
BLSVP8d Quantification in Fresh Leaf
A mature leaf was chosen, total protein content was determined
by Bradford and BLSVP8d was quantiﬁed by densitometry
against a BSA standard by SDS-PAGE followed by Coomassie
blue staining. BLSVP8d expression accounted for, at least,
40% of TSP or 4.85 mg/g fresh tissue, which represents
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FIGURE 4 | BLSVP8d solubility and stability in fresh and lyophilized leaves. 12.5% SDS-PAGE gels stained with Coomassie brilliant blue showing total (T),
soluble (S), and insoluble (I) protein fractions from: (A) 2 mg of transplastomic WT, BLSVP8d, and VP8∗ leaves extracted in Laemmli buffer. VP8∗ was included as an
insoluble control. (B) 0.25 mg of transplastomic WT and BLSVP8d leaves from lyophilized leaves stored at −80◦C and extracted in Laemmli buffer. Total extracts
(3 mg) from wild-type and BLSVP8d fresh leaves were included as controls. (C) 0.25 mg of lyophilized leaves stored at room temperature for one month and
extracted in Laemmli buffer. A total extract (2 mg) from a BLSVP8d fresh leaf was included as control. BLSVP8d, VP8∗, RbcL, and molecular weight marker (Broad
Range Protein Molecular Weight Markers) positions are indicated on the margins.
roughly 10 times the previously observed levels for VP8∗
(Figure 3C).
Stability and Solubility in Fresh and
Lyophilized Leaf Material
In a preliminary analysis, both VP8∗ and BLSVP8d proved to
be insoluble when expressed from their respective chloroplast
transformation vectors in E. coli. Since the majority of VP8∗
also accumulated as inclusion bodies in the chloroplast stroma
and several sonication pulses were necessary in order to have
it extracted in a saline buﬀer compatible with immunization
studies (Lentz et al., 2011), BLSVP8d solubility in fresh
leaves was assayed. Therefore, leaf extracts from wild-type,
BLSVP8d and VP8∗ plants containing total (T), soluble (S), and
insoluble (I) protein were compared by SDS-PAGE followed
by Coomassie blue staining. As expected, VP8∗ was mostly
insoluble. Surprisingly, BLSVP8d mainly remained soluble in
fresh leaf chloroplasts (Figure 4A). Identity of recombinant
protein bands was conﬁrmed by western blot (not shown).
Extracts from lyophilized transplastomic and wild-type
leaves were analyzed in parallel by SDS-PAGE followed by
Coomassie blue staining. BLSVP8d fusion remained stable and
soluble even after lyophilization (Figure 4B). Comparing these
extracts to their respective total extracts from fresh leaves,
extracts from lyophilized leaves presented more degradation
of endogenous proteins, which meant intact BLSVP8d become
slightly more concentrated after lyophilization. As a result,
soluble BLSVP8d extracts from lyophilized leaves were also
included in immunization assays.
The soluble and stable nature of BLSVP8d remained unaltered
even after storage for one month at room temperature
(Figure 4C).
Immune Response to Transplastomic
BLSVP8d
Immunoglobulin Y antibodies speciﬁc to BLSVP8d could be
detected by ELISA after immunization of hens with either
fresh or lyophilized transplastomic soluble protein extracts. No
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speciﬁc antibodies could be detected after immunization with the
respective wild-type extracts. Overall, the response was slightly
faster for fresh extracts. Antibody titers reached 12800 and
ranged between 3200 and 12800 for fresh and lyophilized extracts,
respectively (Figure 5A).
A virus neutralization assay was performed to assess the
ability of these speciﬁc IgY antibodies to prevent bovine rotavirus
infection in vitro. The anti-BLSVP8d IgY antibodies were able
to neutralize rotavirus infection, in accordance with the results
previously obtained by ELISA. Titers were similar for IgY
antibodies elicited after immunization with both fresh and
lyophilized transplastomic soluble protein extracts, and once
again the response was slightly faster in the case of fresh leaf
extracts. In addition, no neutralizing activity could be detected
for any of the IgY fractions obtained after immunization with the
respective wild-type fresh or lyophilized soluble protein extracts
(Figure 5B).
DISCUSSION
Plastid genome transformation constitutes an advantageous
system for recombinant protein expression. Chloroplast
molecular farming stands out for many reasons, being
of particular interest the reduced manufacturing costs,
the ease of scaling-up, the high expression levels that
are typically obtained and which simplify and reduce the
cost of immunization protocols, the absence of human
pathogens or toxins, the post-translational modiﬁcation
capability, the disulﬁde bond formation and the facilitated
biological containment since chloroplasts are not inherited
in polen. In the last years, several studies have reported
lyophilization of transplastomic leaves expressing vaccine
antigens or biopharmaceuticals, further reducing costs
and facilitating storage, processing and puriﬁcation, which
makes immunization protocols simpler and cost-eﬀective
(Rosales-Mendoza et al., 2009; Soria-Guerra et al., 2009;
Manganelli et al., 2012; Cardona et al., 2013; Kwon et al.,
2013a,b).
In this work, we report for the ﬁrst time the production
of transplastomic plants expressing a recombinant fusion of
BLS, a highly immunogenic decameric protein from Brucella
spp, to an antigen. We have recently succeeded in producing
transplastomic tobacco which expressed BRVC486VP8∗ protein,
an interesting target for vaccine development since it is
involved in rotavirus infectivity and neutralization. Based on our
previous work, BLS was coupled to VP8d, a shorter fragment
of VP8∗, and transplastomic BLSVP8d plants were obtained.
Since properly folded BLSVP8d had already been produced
in bacteria and its potent immunomodulatory properties had
already been demonstrated in femalemice and laying henmodels,
it was a good candidate to further analyze its immunogenic
properties in a recombinant plant system (Bellido et al., 2009,
2012).
Our results show that BLSVP8d was highly expressed in
soluble form in plants, accounting for 40% of TSP or 4.85 mg per
gram of fresh leaf tissue, which is approximately one order above
the level obtained for VP8∗ using the same transformation vector.
In the same manner as VP8∗, BLSVP8d readily accumulated
in young leaves and remained stable in mature and senescent
leaves of transplastomic plants. Stable BLSVP8d become more
evident with leaf age as the content of RuBisCo and other
proteins declined, meaning older leaves had greater BLSVP8d
expression than the one reported for an intermediate mature
leaf. Similar pattern of degradation of protein content was also
observed for lyophilized leaves, which could also contribute to
additional concentration of intact BLSVP8d. Our group has
previously shown the capability of transplastomic tobacco to
produce large quantities of immunogenic proteins without any
observable phenotypic eﬀects. Such is the case of VP1 peptide
from the foot and mouth disease virus (FMDV) fused to the
β-glucuronidase enzyme, in which expression levels (51% of TSP)
FIGURE 5 | Detection of specific neutralizing immunoglobulin Y (IgY) antibodies against BLSVP8d after immunization of hens with either fresh or
lyophilized transplastomic soluble protein extracts. (A) Detection of specific IgY antibodies in egg yolk obtained from hens immunized with total soluble protein
extracts. Titers are indicated both for fresh (dark bars) and lyophilized (light bars) samples. Animals received three doses containing 3.83 μg of BLSVP8d (2 μg
corresponded to VP8d). As a control, groups of hens were also immunized with total soluble protein extracts obtained from fresh and lyophilized wild-type leaves.
Purified IgY response was evaluated by ELISA. Titers were expressed as the reciprocal of the highest IgY dilution which gave an OD value above the mean values of
the respective control samples plus 3 standard deviations. (B) Viral neutralization assay to assess the prevention of bovine rotavirus infection in vitro conferred by
specific IgY antibodies. Titers were expressed by the Reed and Muench’s (1938) method considering the highest dilution that resulted in an 80% reduction of
fluorescent foci. Titers are indicated both for fresh (dark bars) and lyophilized (light bars) samples. An IgY fraction obtained by immunization of a hen with BLSVP8d
previously produced in E. coli was included as control (white bar).
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were clearly higher than those of RuBisCo large subunit, the
most abundant leaf protein in a wild-type plant (Lentz et al.,
2009). Transplastomic BLSVP8d levels were also similar to, or
greater than, those of RuBisCo depending on the age of the
analyzed leaf. The drastic increase in the expression levels of
BLSVP8d compared to VP8∗ could not be solely attributed
to the fusion to BLS, since VP8d is almost one third smaller
having truncated amino and carboxi-termini. Nevertheless,
C-terminal fusion to BLS did not appear to be unstabilizing at
all in the chloroplast stroma and although proper folding was
not established in plants, BLS fusion protein decamers could
account for reduced proteolytic degradation and protection.
Despite the high expression levels, wild-type and transplastomic
BLSVP8d plants were phenotypically indistinguishable from each
other.
Since plastids are evolutionarily derived from bacteria,
and both share compatible transcriptional and translational
machinery, expression analysis from the transformation vector
was ﬁrst assessed in E. coli. Nevertheless, accumulation and
stability could not be accurately predicted in this prokaryotic
model. BLSVP8d was highly expressed in bacteria but formed
inclusion bodies. VP8∗ was also mainly expressed as inclusion
bodies either in bacteria and chloroplasts. Interestingly,
despite its higher expression levels, we demonstrated that
transplastomic BLSVP8d always remained soluble, even in
senescent or lyophilized leaves. Furthermore, storage of
lyophilized material for up to one month at room temperature
did not show any sign of degradation or altered solubility
of BLSVP8d. The observed diﬀerence in solubility between
VP8∗ and BLSVP8d could not be entirely associated with
the addition of BLS since VP8∗ and VP8d have diﬀerent
length. However, by no means the multimeric nature of
BLS was detrimental for the solubility of the fusion as a
whole.
Our work also demonstrated that hen immunization with
unpuriﬁed transplastomic BLSVP8d soluble extracts from both
fresh and liophylized leaves induced IgY speciﬁc neutralizing
antibodies in egg yolk, as measured by ELISA and in vitro
neutralization assays. Immunization results could not be directly
compared to those obtained for VP8∗ due to its diﬀerence in
length, but all our previous results with BLSVP8d expressed
in bacteria suggest that potentially enhanced immunogenicity
should also be the case in plants. Currently ongoing research
is aimed to ascertain this and to assess stability, solubility
and proper folding of BLSVP8d multimers coming from
lyophilized extracts after longer storage at room temperature.
Moreover, dietary uptake of powdered egg yolk speciﬁc IgY
antibodies could be exploited in the future as an approach
to confer passive protection against rotavirus (Vega et al.,
2012).
CONCLUSION
The BLS scaﬀold was assessed for the ﬁrst time in plants.
BLSVP8d was highly expressed in tobacco chloroplasts,
remaining soluble and stable during all stages of plant
development, even in senescent or lyophilized leaves.
Furthermore, fresh and lyophilized leaf unpuriﬁed soluble
extracts were able to induce speciﬁc neutralizing IgY antibodies
in a laying hen model. This work presents BLS as an interesting
platform for a plant-based highly immunogenic injectable, or
even oral, VP8∗ subunit vaccine.
Our ﬁndings provide the basis for the expression of other
subset of antigens fused to the potent immunomodulator
BLS and suggest that lyophilization, without the need for
additional lyoprotective components, of transplastomic leaves
expressing antigenic fusions can further reduce costs and simplify
downstream processing, puriﬁcation and storage, allowing for
more rational injectable or oral vaccines.
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